Featured,Shroom News,Spotlight Stock Atai Life Sciences Acquires Majority Stake in Psyber Inc. By Dennis Mutua April 08, 2021 New York based psychedelic and mental health company Atai Life Sciences announced having acquired a majority stake in Delaware based Psyber Inc. Psyber majorly engages in developing interventions to improve various mental health d...
Shroom News,Spotlight Stock Entheon Unveils Psychedelics Genetic Test by its Subsidiary Halugen By Dennis Mutua April 07, 2021 Biotech company with a special focus on developing psychedelic medicines to treat addiction Entheon BioMedical Corp. (CNSX: ENBI) has unveiled a psychedelics genetic test kit fully developed by its wholly owned subsidiary HaluGen ...
Psychedelic Stocks,Shroom News MindMed Publishes New Data on MDMA Dosing By Dennis Mutua April 06, 2021 Leading clinical-stage psychedelic medicine biotech company Mind Medicine Inc. (OTCQB: MMEDF) has published a new set of data on Personalized MDMA Dosing. The study was conducted in the University Hospital Basel Liechti Lab, in ...
Psychedelic Stocks,Shroom News University of California Launches a Psychedelics Research Division By Dennis Mutua April 05, 2021 The University of California, San Francisco, announced having launched a research division in psychedelic studies. The university received private financing amounting to $6.4 million to kick start operations in the newly launch...
Shroom News,Spotlight Stock Tryp Therapeutics Appoints Greg McKee as New CEO By Dennis Mutua April 02, 2021 Pharmaceutical company Tryp Therapeutics Inc. (CNSX: TRYP) has appointed Greg McKee as its new Chief Executive Officer. Following this appointment, MCKee will double up as the CEO and Chairman of the Board of Directors at the comp...
Featured,Shroom News Oregon on the Brink of Becoming the First State to Authorize Therapeutic Use of Psychedelic Mushrooms By Dennis Mutua April 01, 2021 Oregon is on the verge of becoming the first State in the United States to legalize therapeutic use of psychedelic mushrooms in licensed facilities under the guidance of professionally trained personnel to oversee psychedelic acti...
Psychedelic Stocks,Shroom News Psirenity Approved to Conduct Psilocybin Clinical Trial on Depression in Jamaica By Dennis Mutua March 31, 2021 The subsidiary of New Leaf Canada Inc. (NLVVF), Psirenity, has been approved to conduct its psilocybin clinical trial on depression control in Jamaica. This will go on record as the first clinical trial of this kind the company wi...
Psychedelic Stocks,Shroom News Nova Mentis Announces Positive Results in Study Related to ASD By Dennis Mutua March 30, 2021 Biotech company and market leader in making diagnostics psychedelics Nova Mentis Life Science Corp. (CNSX: NOVA) (OTCQB: NMLSF) announced promising results of its ongoing study of using psilocybin on anxiety behaviors linked to Au...